Silver Spring, Maryland–(ENEWSPF)–August 27, 2012. Samantha Lynn Inc. is voluntarily recalling 500 lots of Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients.
Samantha Lynn Inc. Issues Voluntary Nationwide Recall of Reumofan Plus Tablets Due to Undeclared Drug Ingredients
More in Recalls:
-
Conagra Brands, Inc., Recalls Frozen Beef Products Due to Misbranding and Undeclared Allergens
August 12, 2022
-
BrucePac Recalls Ready-to-Eat Chicken Sausage Products Due to Misbranding
November 20, 2019
-
Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA
November 14, 2018
